Inside the Air Force family’s foyer, Francis was greeted by the babysitters’ father. While they waited for Jacquie to come ...

In the fifty-plus years that I’ve been doing yard work, I’ve never suffered more than the occasional minor cuts, abrasions ...

Keep an eye on the site, which will often heal on its own without stitches or other treatment. Don't use a topical ointment like Neosporin on a cut in your mouth, or in your nose or eyes. If you have ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on w ...

A new study from the Koret School of Veterinary Medicine at Hebrew University has brought new insights into Florida spot ...

The pandemic caused an overall decrease in the rates of the 10 most common ophthalmic procedures performed in 2020 when ...

Heart Eyes' director Josh Ruben talks about combining Nora Ephron and 'Friday the 13th' to make an iconic killer for a new ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

Holiday rom-com lovers who are also slasher film completists: That’s the coterie that might go for Josh Ruben’s “Heart Eyes,” a romantic comedy feebly masquerading as a horror movie.

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).